Athlete's foot

Dr. Scholl's® Teams Up with Former Professional Football Coach and Self-Proclaimed Foot Expert Rex Ryan to Launch New Instant Cool Athlete's Foot Solutions

Retrieved on: 
Wednesday, September 14, 2022
Athlete, Movement, Foot, Partnership, UNC, Breeding, Pain, University of North Carolina at Pembroke, Athlete's foot, Ankle, Science, Fowler & Wells Company, Food, Scholl, Awareness, Marketing, Dr. Scholl's, Fatigue, University, SVP, Education, TLC, Sports equipment, Distribution (marketing)

PARSIPPANY, N.J., Sept. 14, 2022 /PRNewswire/ -- Dr. Scholl's®, the most trusted brand in foot care, today announced a partnership with former head football coach and analyst Rex Ryan in celebration of its new Instant Cool Athlete's Treatment Spray and Wipes. In this role, Ryan will utilize his notorious foot expertise to mentor the University of North Carolina football team with his "toe tips" on proper foot care maintenance.

Key Points: 
  • In this role, Ryan will utilize his notorious foot expertise to mentor the University of North Carolina football team with his "toe tips" on proper foot care maintenance.
  • "Two things are for certain: I know football, and I know feet," said Ryan.
  • So, treating quickly with Dr. Scholl's Instant Cool Athlete's Foot Solutions gives athletes and non-athletes alike instant cooling to minimize the physical and emotional discomfort that often accompanies the common condition."
  • Dr. Scholl's Instant Cool Athlete's Foot Treatments are available for purchase on www.drscholls.com and at food, drug, and mass stores nationwide.

Athlete's Foot (Tinea Pedis) Epidemiology Forecast/Research Report 2022-2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 4, 2022
Health, General Health, United Kingdom, Disease, Table, Athlete's foot, Epidemiology, Dermatophytosis, Diagnosis, Classification, The Athlete's Foot, Fashion, Renewable energy, Athlete

This "Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Athlete's Foot (Tinea Pedis) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Key Points: 
  • This "Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Athlete's Foot (Tinea Pedis) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Athlete's Foot (Tinea Pedis) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries.
  • The Athlete's Foot (Tinea Pedis) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.
  • The Athlete's Foot (Tinea Pedis) epidemiology covered in the report provides historical as well as forecasted Athlete's Foot (Tinea Pedis) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

DermBiont Announces Positive Results from Phase 2b Clinical Trial in Tinea Pedis

Retrieved on: 
Friday, January 8, 2021
Infectious diseases, Medical specialties, Branches of biology, Dermatophytosis, Onychomycosis, Athlete's foot, Placebo-controlled study, Mycosis

"We have demonstrated the clinical efficacy of DBI-001 in tinea pedis and have significantly deepened our industry leading understanding of the skin microbiome and how to develop live biotherapeutics as drug products."

Key Points: 
  • "We have demonstrated the clinical efficacy of DBI-001 in tinea pedis and have significantly deepened our industry leading understanding of the skin microbiome and how to develop live biotherapeutics as drug products."
  • This positive data builds upon earlier positive phase 2a results and supports the ongoing development and advancement of DBI-001 for the treatment of tinea pedis (athlete's foot) and onychomycosis (toenail fungus).
  • The phase 2b double blind placebo-controlled trial follows DermBiont's phase 2a trial with DBI-001 for the treatment of tinea pedis.
  • The phase 2a trial entailed a single application of drug product to patients' feet while phase 2b trial patients self-applied DBI-001 to their feet once daily for 28 days.

InventHelp Inventor Develops Footwear Accessory to Keep Feet Dry & Comfortable (HLW-2290)

Retrieved on: 
Thursday, November 5, 2020
Footwear, Medical specialties, Foot diseases, Blister, Shoe, Organ systems, Athlete's foot, Hyperhidrosis, Anatomy, Foot

I needed a way to keep my feet and footwear dry and comfortable without slipping, so I invented the HEEL SCHOOL FOR HYPERHIDROSIS BUDDY.

Key Points: 
  • I needed a way to keep my feet and footwear dry and comfortable without slipping, so I invented the HEEL SCHOOL FOR HYPERHIDROSIS BUDDY.
  • The invention provides an effective way to keep feet dry and odor free while wearing shoes.
  • In doing so, it reduces the growth of bacteria, athlete's foot, blisters and other ailments caused by damp feet.
  • The invention features a user-friendly design that is easy to position and use so it is ideal for men, women and children.

InventHelp Inventor Presents a Drying Accessory (SKC-596)

Retrieved on: 
Wednesday, September 2, 2020
Foot diseases, Athlete's foot, RTT, Itch, Medical specialties, Clinical medicine, Medicine

"As I got older, I realized how much harder it is to thoroughly dry my feet and torso.

Key Points: 
  • "As I got older, I realized how much harder it is to thoroughly dry my feet and torso.
  • With damp feet comes athletes foot and without a dry lower torso you can get jock itch", said the inventor.
  • The original design was submitted to the National sales office of InventHelp.
  • InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

InventHelp Inventor Develops Waterproof Foot Covering Worn Inside Shoes (NWO-414)

Retrieved on: 
Tuesday, September 1, 2020
Foot diseases, Athlete's foot, RTT, Sock, Damp

Fortunately, an inventor from Hattiesburg, Miss., has conceived a way to keep feet dry when walking or working in rain, snow or other wet or damp conditions.

Key Points: 
  • Fortunately, an inventor from Hattiesburg, Miss., has conceived a way to keep feet dry when walking or working in rain, snow or other wet or damp conditions.
  • SOCK STOP was developed to provide enhanced foot comfort in such cases and reduce the chances of athlete's foot, fungus and other irritations to the feet.
  • As such, it is versatile for use while engaging in any outdoor activity in wet or cold weather.
  • The original design was submitted to the New Orleans sales office of InventHelp.

InventHelp Inventor Develops New Skin Care Product to Relieve Various Conditions (HTT-7334)

Retrieved on: 
Wednesday, June 24, 2020
RTT, Dermatitis, Athlete's foot, Medical specialties, Medicine, Skin care, Immunology, Ageing

The invention provides an effective way to help relieve foot fungus, eczema and other skin conditions.

Key Points: 
  • The invention provides an effective way to help relieve foot fungus, eczema and other skin conditions.
  • In doing so, it offers an alternative to traditional creams and skin care products.
  • As a result, it could provide the user with softer, more attractive skin and it enhances comfort and convenience.
  • The invention features a user-friendly design that is easy to apply and use so it is ideal for individuals age 12 and older.

Athlete's Foot - Market Insights, Epidemiology and Forecast to 2030

Retrieved on: 
Thursday, June 4, 2020
Medicine, RTT, Athlete's foot, The Athlete's Foot, Articles, Epidemiology, Disease, Health

DUBLIN, June 4, 2020 /PRNewswire/ -- The "Athlete's Foot - Market Insights, Epidemiology and Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 4, 2020 /PRNewswire/ -- The "Athlete's Foot - Market Insights, Epidemiology and Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of the Athlete's foot, historical and forecasted epidemiology as well as the Athlete's foot market trends in the United States.
  • The market report provides current treatment practices, emerging drugs, Athlete's foot market share of the individual therapies, current and forecasted Athlete's foot market Size from 2017 to 2030.
  • The disease epidemiology covered in the report provides historical as well as forecasted Athlete's foot epidemiology [segmented as Diagnosed Incident cases of Athlete's foot and Incident cases of Athlete's foot by subtype] scenario of Athlete's foot in the United States from 2017 to 2030.

Athlete's Foot Research Study 2020 - Global Market Size, Epidemiology, Marketed & Emerging Drugs, Pipeline Activities, Reimbursement Scenario, Competitive Intelligence (2017-2030) - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 4, 2020
Health, Pharmaceutical, Strategic management, Business intelligence, Articles, Economy, Market research, Competition, Marketing strategy, SWOT analysis, Athlete's foot, Competitive intelligence, The Athlete's Foot, Marketing

The market report provides current treatment practices, emerging drugs, Athlete's foot market share of the individual therapies, current and forecasted Athlete's foot market size from 2017 to 2030.

Key Points: 
  • The market report provides current treatment practices, emerging drugs, Athlete's foot market share of the individual therapies, current and forecasted Athlete's foot market size from 2017 to 2030.
  • The Athlete's foot epidemiology division provide the insights about historical and current Athlete's foot patient pool and forecasted trend for the United States.
  • Drug chapter segment of the Athlete's foot report encloses the detailed analysis of Athlete's foot marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
  • The publisher performs Competitive & Market Intelligence analysis of the Athlete's foot Market by using various Competitive Intelligence tools that includes - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc.

Tinea Pedis Clinical Development Scenario and Growth Prospects, 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 21, 2020
Health, Pharmaceutical, RTT, Dermatophytosis, Athlete's foot, Veterinary medicine, Medicine, Health

Tinea Pedis Pipeline Insight, 2020 outlays comprehensive insights of present clinical development scenario and growth prospects across the Tinea Pedis market.

Key Points: 
  • Tinea Pedis Pipeline Insight, 2020 outlays comprehensive insights of present clinical development scenario and growth prospects across the Tinea Pedis market.
  • A detailed picture of the Tinea Pedis pipeline landscape is provided, which includes the disease overview and Tinea Pedis treatment guidelines.
  • The assessment part of the report embraces in-depth Tinea Pedis commercial assessment and clinical assessment of the Tinea Pedis pipeline products from the pre-clinical developmental phase to the marketed phase.
  • How many Tinea Pedis emerging therapies are in early-stage, mid-stage, and late stage of development for the treatment of Tinea Pedis?